首页 > 最新文献

Journal of Clinical Anesthesia最新文献

英文 中文
Editorial Board w/barcode 编辑委员会/条形码
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-02-01 Epub Date: 2026-01-09 DOI: 10.1016/S0952-8180(26)00004-8
{"title":"Editorial Board w/barcode","authors":"","doi":"10.1016/S0952-8180(26)00004-8","DOIUrl":"10.1016/S0952-8180(26)00004-8","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112126"},"PeriodicalIF":5.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145938763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The fascial plane blocks in the upper arm surgery and trauma: A narrative review 上臂手术与创伤中的筋膜面阻滞:叙述性回顾。
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-27 DOI: 10.1016/j.jclinane.2025.112115
Francesco Marrone , Lorenza Sbucafratta , Pierfrancesco Fusco
Fascial plane blocks are becoming popular as useful and safe methods to provide pain relief. While their use in thoracic and abdominal surgery is well known, their application in upper arm surgery and trauma is underscored. This review explores research from the last 10 years focusing the use of fascial plane blocks to relieve pain after surgery or trauma in the upper limb. Studies include randomized controlled trials, observational studies, and case reports. They look at techniques like the cervical and high-thoracic erector spinae plane (ESP) block, the clavipectoral fascia plane (CFP) block, the superior posterior serratus intercostal plane (SPSIP) block, and periarticular approaches like the pericapsular (PENG) shoulder block. The high-thoracic ESP block provided pain relief and was often given with a continuous catheter infusion. The research shows that there is a tendency toward combining fascial blocks with each other or with peripheral nerve blocks to cover more area and cut down on the use of opioids. Even if the results are promising, there aren't many randomized trials in the literature, thus data are still mostly low-quality level. Risk of potential complications, such as local anesthetic systemic toxicity (LAST) or unintentional dissemination to important anatomical areas, exists although not reported. This study shows how fascial plane blocks in upper limb surgery are changing and recommends for more high-quality research to find out when they are best used, how safe they are, and how well they may work.
筋膜平面阻滞作为一种有效且安全的止痛方法正变得越来越受欢迎。虽然它们在胸部和腹部手术中的应用是众所周知的,但它们在上臂手术和创伤中的应用是强调的。这篇综述探讨了近10年来关于使用筋膜平面阻滞来缓解上肢手术或创伤后疼痛的研究。研究包括随机对照试验、观察性研究和病例报告。他们研究了颈椎和胸高段竖脊肌平面(ESP)阻滞、锁骨筋膜平面(CFP)阻滞、上后锯肌肋间平面(SPSIP)阻滞和关节周围入路(如肩关节囊周阻滞)等技术。高胸段ESP阻滞可缓解疼痛,且常伴有持续导管输注。研究表明,有一种趋势是将筋膜阻滞相互结合或与周围神经阻滞相结合,以覆盖更多的区域,减少阿片类药物的使用。即使结果很有希望,文献中也没有多少随机试验,因此数据仍然大多是低质量的。潜在并发症的风险,如局麻全身毒性(LAST)或意外传播到重要解剖区域,虽然没有报道,但存在。这项研究显示了筋膜平面阻滞在上肢手术中的变化,并建议进行更多高质量的研究,以找出最佳使用时间、安全性和效果。
{"title":"The fascial plane blocks in the upper arm surgery and trauma: A narrative review","authors":"Francesco Marrone ,&nbsp;Lorenza Sbucafratta ,&nbsp;Pierfrancesco Fusco","doi":"10.1016/j.jclinane.2025.112115","DOIUrl":"10.1016/j.jclinane.2025.112115","url":null,"abstract":"<div><div>Fascial plane blocks are becoming popular as useful and safe methods to provide pain relief. While their use in thoracic and abdominal surgery is well known, their application in upper arm surgery and trauma is underscored. This review explores research from the last 10 years focusing the use of fascial plane blocks to relieve pain after surgery or trauma in the upper limb. Studies include randomized controlled trials, observational studies, and case reports. They look at techniques like the cervical and high-thoracic erector spinae plane (ESP) block, the clavipectoral fascia plane (CFP) block, the superior posterior serratus intercostal plane (SPSIP) block, and periarticular approaches like the pericapsular (PENG) shoulder block. The high-thoracic ESP block provided pain relief and was often given with a continuous catheter infusion. The research shows that there is a tendency toward combining fascial blocks with each other or with peripheral nerve blocks to cover more area and cut down on the use of opioids. Even if the results are promising, there aren't many randomized trials in the literature, thus data are still mostly low-quality level. Risk of potential complications, such as local anesthetic systemic toxicity (LAST) or unintentional dissemination to important anatomical areas, exists although not reported. This study shows how fascial plane blocks in upper limb surgery are changing and recommends for more high-quality research to find out when they are best used, how safe they are, and how well they may work.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112115"},"PeriodicalIF":5.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145850418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pupillometry and pre-operative cognitive function: A possible new tool in identifying a frail brain 瞳孔测量和术前认知功能:一种可能的识别脆弱大脑的新工具。
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-29 DOI: 10.1016/j.jclinane.2025.112119
Paolo Zanatta , Andrea Rossi , Giorgio Fullin , Luigi Polesello , Alice Baruffol , Federico Linassi
{"title":"Pupillometry and pre-operative cognitive function: A possible new tool in identifying a frail brain","authors":"Paolo Zanatta ,&nbsp;Andrea Rossi ,&nbsp;Giorgio Fullin ,&nbsp;Luigi Polesello ,&nbsp;Alice Baruffol ,&nbsp;Federico Linassi","doi":"10.1016/j.jclinane.2025.112119","DOIUrl":"10.1016/j.jclinane.2025.112119","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112119"},"PeriodicalIF":5.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145863120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preoperative SGLT2i therapy and acute kidney injury in patients undergoing emergency and urgent coronary artery bypass grafting - A causal inference framework 急诊和紧急冠状动脉旁路移植术患者术前SGLT2i治疗与急性肾损伤的因果推断框架
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-15 DOI: 10.1016/j.jclinane.2025.112103
Michael Kolland , Selina Sartori , Christoph Klivinyi , Michael Schörghuber , Jakob Pannold , Igor Knez , Alexander H. Kirsch , Nikolaus Schreiber

Background

Acute kidney injury (AKI) is a common complication after coronary artery bypass grafting (CABG), associated with adverse short- and long-term outcomes. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been shown to reduce occurrence of AKI in several populations, yet their perioperative effects in patients undergoing CABG are unknown.

Methods

We conducted a retrospective study at the Department of Cardiac Surgery, Medical University of Graz (2020–2024) to evaluate the impact of preoperative SGLT2i use on cardiac surgery–associated AKI in adults undergoing urgent or emergent isolated coronary artery bypass grafting in patients with an indication for SGLT2i therapy (type 2 diabetes mellitus, heart failure with reduced ejection fraction, or chronic kidney disease). Patients with preoperative dialysis, sepsis, reoperation, mechanical circulatory support or missing laboratory data were excluded. Exposure was defined as SGLT2i use within two weeks before surgery, and the primary outcome was cardiac surgery-associated AKI (CSA-AKI) according to KDIGO criteria. Secondary outcomes included kidney replacement therapy, ICU length of stay, 30-day mortality and postoperative diabetic ketoacidosis. Causal effects were estimated using entropy balancing. Results were reported as weighted risk differences, risk ratios, and adjusted mean differences, with time-to-event outcomes analyzed via weighted Cox models and Kaplan–Meier estimates.

Results

Among 484 patients, 135 were on SGLT2i. CSA-AKI occurred in 23.0 % of SGLT2i users vs. 28.1 % of non-users (risk ratio of 0.63 [95 % CI 0.44–0.91; p = 0.014]). The association was pronounced in patients with heart failure with reduced ejection fraction and those with high EuroSCORE II. No differences were observed in other secondary endpoints and no cases of postoperative diabetic ketoacidosis occurred.

Conclusion

Preoperative SGLT2i use was associated with a significantly lower risk of CSA-AKI in patients undergoing urgent or emergent CABG. These findings need to be confirmed in prospective multicenter trials but underline the favorable safety profile of this medication.
背景:急性肾损伤(AKI)是冠状动脉旁路移植术(CABG)后常见的并发症,与不良的短期和长期预后相关。钠-葡萄糖共转运蛋白-2抑制剂(SGLT2i)已被证明可以减少几个人群AKI的发生,但其在CABG患者的围手术期效果尚不清楚。方法:我们在格拉茨医科大学心脏外科(2020-2024)进行了一项回顾性研究,以评估术前使用SGLT2i对有SGLT2i治疗指征(2型糖尿病、心力衰竭伴射血分数降低或慢性肾病)的成人紧急或紧急孤立冠状动脉旁路移植术中心脏手术相关AKI的影响。排除术前透析、败血症、再手术、机械循环支持或缺少实验室数据的患者。暴露被定义为术前两周内使用SGLT2i,根据KDIGO标准,主要结局是心脏手术相关AKI (CSA-AKI)。次要结局包括肾脏替代治疗、ICU住院时间、30天死亡率和术后糖尿病酮症酸中毒。利用熵平衡估计因果效应。结果报告为加权风险差异、风险比和调整后的平均差异,并通过加权Cox模型和Kaplan-Meier估计分析事件发生时间。结果:484例患者中,有135例接受SGLT2i治疗。SGLT2i使用者中CSA-AKI发生率为23.0%,非使用者中为28.1%(风险比为0.63 [95% CI 0.44-0.91; p = 0.014])。在射血分数降低的心力衰竭患者和EuroSCORE II高的患者中,这种关联明显。其他次要终点无差异,术后无糖尿病酮症酸中毒病例发生。结论:术前使用SGLT2i与急诊或紧急冠脉搭桥患者CSA-AKI风险显著降低相关。这些发现需要在前瞻性多中心试验中得到证实,但强调了该药物的良好安全性。
{"title":"Preoperative SGLT2i therapy and acute kidney injury in patients undergoing emergency and urgent coronary artery bypass grafting - A causal inference framework","authors":"Michael Kolland ,&nbsp;Selina Sartori ,&nbsp;Christoph Klivinyi ,&nbsp;Michael Schörghuber ,&nbsp;Jakob Pannold ,&nbsp;Igor Knez ,&nbsp;Alexander H. Kirsch ,&nbsp;Nikolaus Schreiber","doi":"10.1016/j.jclinane.2025.112103","DOIUrl":"10.1016/j.jclinane.2025.112103","url":null,"abstract":"<div><h3>Background</h3><div>Acute kidney injury (AKI) is a common complication after coronary artery bypass grafting (CABG), associated with adverse short- and long-term outcomes. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been shown to reduce occurrence of AKI in several populations, yet their perioperative effects in patients undergoing CABG are unknown.</div></div><div><h3>Methods</h3><div>We conducted a retrospective study at the Department of Cardiac Surgery, Medical University of Graz (2020–2024) to evaluate the impact of preoperative SGLT2i use on cardiac surgery–associated AKI in adults undergoing urgent or emergent isolated coronary artery bypass grafting in patients with an indication for SGLT2i therapy (type 2 diabetes mellitus, heart failure with reduced ejection fraction, or chronic kidney disease). Patients with preoperative dialysis, sepsis, reoperation, mechanical circulatory support or missing laboratory data were excluded. Exposure was defined as SGLT2i use within two weeks before surgery, and the primary outcome was cardiac surgery-associated AKI (CSA-AKI) according to KDIGO criteria. Secondary outcomes included kidney replacement therapy, ICU length of stay, 30-day mortality and postoperative diabetic ketoacidosis. Causal effects were estimated using entropy balancing. Results were reported as weighted risk differences, risk ratios, and adjusted mean differences, with time-to-event outcomes analyzed via weighted Cox models and Kaplan–Meier estimates.</div></div><div><h3>Results</h3><div>Among 484 patients, 135 were on SGLT2i. CSA-AKI occurred in 23.0 % of SGLT2i users vs. 28.1 % of non-users (risk ratio of 0.63 [95 % CI 0.44–0.91; <em>p</em> = 0.014]). The association was pronounced in patients with heart failure with reduced ejection fraction and those with high EuroSCORE II. No differences were observed in other secondary endpoints and no cases of postoperative diabetic ketoacidosis occurred.</div></div><div><h3>Conclusion</h3><div>Preoperative SGLT2i use was associated with a significantly lower risk of CSA-AKI in patients undergoing urgent or emergent CABG. These findings need to be confirmed in prospective multicenter trials but underline the favorable safety profile of this medication.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112103"},"PeriodicalIF":5.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145768267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The neurocardiac axis in acute intracranial stress 急性颅内应激的神经心脏轴。
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-02-01 Epub Date: 2025-12-17 DOI: 10.1016/j.jclinane.2025.112105
Wesley L. Allen , Kiran S. Merchant , Archer K. Martin, Shaun E. Gruenbaum, Benjamin F. Gruenbaum
Acute intracranial injuries including subarachnoid hemorrhage, traumatic brain injury, stroke, and seizures often trigger cardiovascular and pulmonary complications through the neurocardiac axis. This bidirectional connection between the brain and the heart is mediated by sympathetic overactivity, catecholamine excess, autonomic imbalance, and systemic inflammation. This narrative review synthesizes current evidence published between 1968 and 2025, identified through a comprehensive literature search. Representative studies were selected to provide an integrative overview of neurocardiac complications in acute neurologic injury, focusing on underlying mechanisms, clinical manifestations, diagnostic challenges, and management strategies. We describe the mechanisms underlying neurogenic stunned myocardium and Takotsubo syndrome, highlighting regional vulnerability based on autonomic innervation. Electrocardiographic features, cardiac biomarkers, and echocardiographic findings are discussed in the context of early recognition and risk stratification. We further examine diagnostic challenges, the importance of distinguishing neurologic from primary cardiac pathology, and therapeutic approaches including autonomic modulation and cardiopulmonary protective strategies. Understanding the unique pathogenesis of these syndromes can help guide individualized treatment strategies and anesthetic management to improve outcomes in patients with acute neurologic injury. By consolidating multidisciplinary insights, this review aims to enhance recognition and management of neurocardiac complications in this population.
急性颅内损伤,包括蛛网膜下腔出血、外伤性脑损伤、中风和癫痫发作,常通过神经心脏轴引发心血管和肺部并发症。这种大脑和心脏之间的双向连接是由交感神经过度活跃、儿茶酚胺过量、自主神经失衡和全身炎症介导的。这篇叙述性综述综合了1968年至2025年间发表的现有证据,通过全面的文献检索确定。我们选择了有代表性的研究来提供急性神经损伤的神经心脏并发症的综合概述,重点是潜在的机制、临床表现、诊断挑战和管理策略。我们描述了神经源性休克心肌和Takotsubo综合征的机制,强调了基于自主神经支配的区域易感性。在早期识别和风险分层的背景下,讨论了心电图特征、心脏生物标志物和超声心动图的发现。我们进一步研究了诊断挑战,区分神经系统和原发性心脏病理的重要性,以及包括自主神经调节和心肺保护策略在内的治疗方法。了解这些综合征的独特发病机制有助于指导个体化治疗策略和麻醉管理,以改善急性神经损伤患者的预后。通过整合多学科的见解,本综述旨在提高这一人群对神经心脏并发症的认识和管理。
{"title":"The neurocardiac axis in acute intracranial stress","authors":"Wesley L. Allen ,&nbsp;Kiran S. Merchant ,&nbsp;Archer K. Martin,&nbsp;Shaun E. Gruenbaum,&nbsp;Benjamin F. Gruenbaum","doi":"10.1016/j.jclinane.2025.112105","DOIUrl":"10.1016/j.jclinane.2025.112105","url":null,"abstract":"<div><div>Acute intracranial injuries including subarachnoid hemorrhage, traumatic brain injury, stroke, and seizures often trigger cardiovascular and pulmonary complications through the neurocardiac axis. This bidirectional connection between the brain and the heart is mediated by sympathetic overactivity, catecholamine excess, autonomic imbalance, and systemic inflammation. This narrative review synthesizes current evidence published between 1968 and 2025, identified through a comprehensive literature search. Representative studies were selected to provide an integrative overview of neurocardiac complications in acute neurologic injury, focusing on underlying mechanisms, clinical manifestations, diagnostic challenges, and management strategies. We describe the mechanisms underlying neurogenic stunned myocardium and Takotsubo syndrome, highlighting regional vulnerability based on autonomic innervation. Electrocardiographic features, cardiac biomarkers, and echocardiographic findings are discussed in the context of early recognition and risk stratification. We further examine diagnostic challenges, the importance of distinguishing neurologic from primary cardiac pathology, and therapeutic approaches including autonomic modulation and cardiopulmonary protective strategies. Understanding the unique pathogenesis of these syndromes can help guide individualized treatment strategies and anesthetic management to improve outcomes in patients with acute neurologic injury. By consolidating multidisciplinary insights, this review aims to enhance recognition and management of neurocardiac complications in this population.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"109 ","pages":"Article 112105"},"PeriodicalIF":5.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145781166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacogenetics in perioperative care: Understanding the impact of genetic variants on patient management 围手术期护理中的药物遗传学:了解遗传变异对患者管理的影响
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-01 DOI: 10.1016/j.jclinane.2025.112064
Jan Albert Nicolaas Groot , Ankie Maxelante Harmsze , Eric Hendricus Paulus Adrianus van Dongen , Catherijne Anette Jantine Knibbe , Helena Johanna Blussé van Oud-Alblas
Despite advances in perioperative medicine, variability in patient responses to commonly administered anesthetic and analgesic agents remains a clinical challenge. Genetic factors are increasingly proposed contributors to these interindividual differences, yet much of the supporting evidence remains preliminary, heterogeneous or insufficiently validated. Pharmacogenetics has emerged as a promising field to improve therapeutic precision. However, its clinical application in perioperative care remains limited. This narrative review critically appraises pharmacokinetic and pharmacodynamic drug–gene interactions that influence responses to routinely administered agents. Genetic variations affect multiple aspects of perioperative care, including drug metabolism and receptor sensitivity, pain processing, autonomic function, and susceptibility to complications such as postoperative nausea and vomiting and opioid-induced respiratory depression. A better understanding of drug–gene interactions may help anesthesiologists identify patients with atypical sensitivity or resistance to commonly used agents, as well as those at increased risk for perioperative complications. Integration of pharmacogenetic data into perioperative decision-making may facilitate individualized care, but broader implementation will require replication in diverse cohorts, prospective clinical validation and development of evidence-based guidelines.
尽管围手术期医学有所进步,但患者对常用麻醉和镇痛药物反应的变异性仍然是一个临床挑战。越来越多的人提出遗传因素是造成这些个体间差异的原因,但许多支持证据仍然是初步的、异质的或未充分验证的。药物遗传学已成为提高治疗精度的一个有前途的领域。然而,其在围手术期护理中的临床应用仍然有限。这篇叙述性综述批判性地评价了影响常规用药反应的药代动力学和药效学药物-基因相互作用。遗传变异影响围手术期护理的多个方面,包括药物代谢和受体敏感性、疼痛处理、自主神经功能以及术后恶心呕吐和阿片类药物引起的呼吸抑制等并发症的易感性。更好地了解药物-基因相互作用可以帮助麻醉师识别对常用药物非典型敏感或耐药的患者,以及那些围手术期并发症风险增加的患者。将药物遗传学数据整合到围手术期决策中可能有助于个体化护理,但更广泛的实施将需要在不同的队列中进行复制、前瞻性临床验证和制定循证指南。
{"title":"Pharmacogenetics in perioperative care: Understanding the impact of genetic variants on patient management","authors":"Jan Albert Nicolaas Groot ,&nbsp;Ankie Maxelante Harmsze ,&nbsp;Eric Hendricus Paulus Adrianus van Dongen ,&nbsp;Catherijne Anette Jantine Knibbe ,&nbsp;Helena Johanna Blussé van Oud-Alblas","doi":"10.1016/j.jclinane.2025.112064","DOIUrl":"10.1016/j.jclinane.2025.112064","url":null,"abstract":"<div><div>Despite advances in perioperative medicine, variability in patient responses to commonly administered anesthetic and analgesic agents remains a clinical challenge. Genetic factors are increasingly proposed contributors to these interindividual differences, yet much of the supporting evidence remains preliminary, heterogeneous or insufficiently validated. Pharmacogenetics has emerged as a promising field to improve therapeutic precision. However, its clinical application in perioperative care remains limited. This narrative review critically appraises pharmacokinetic and pharmacodynamic drug–gene interactions that influence responses to routinely administered agents. Genetic variations affect multiple aspects of perioperative care, including drug metabolism and receptor sensitivity, pain processing, autonomic function, and susceptibility to complications such as postoperative nausea and vomiting and opioid-induced respiratory depression. A better understanding of drug–gene interactions may help anesthesiologists identify patients with atypical sensitivity or resistance to commonly used agents, as well as those at increased risk for perioperative complications. Integration of pharmacogenetic data into perioperative decision-making may facilitate individualized care, but broader implementation will require replication in diverse cohorts, prospective clinical validation and development of evidence-based guidelines.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"108 ","pages":"Article 112064"},"PeriodicalIF":5.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145418670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effectiveness of preoperative oral carbohydrate loading on postoperative nausea and vomiting in adults receiving total intravenous anaesthesia compared to inhalational anaesthesia: A systematic review and meta-analysis 与吸入麻醉相比,术前口服碳水化合物负荷对接受全静脉麻醉的成人术后恶心和呕吐的影响:一项系统回顾和荟萃分析。
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-16 DOI: 10.1016/j.jclinane.2025.112075
Oya Gumuskaya , Hailey R. Donnelly , Nick Glenn , Julee McDonagh , Anita Skaros , Sophie Liang , Brett G. Mitchell , Luke Bendle , Sarah Aitken , Emile Belramoul , Mitchell Sarkies

Background

Preoperative oral carbohydrate loading is thought to reduce postoperative nausea and vomiting (PONV). However, it is unknown if the benefit of carbohydrate loading is maintained in the presence of total intravenous anaesthesia (TIVA). The aim of this systematic review was to determine whether oral carbohydrate loading reduced PONV compared to overnight fasting between adult elective surgery patients receiving TIVA or inhalational general anaesthesia.

Methods

A search of seven databases was conducted until March 2024. Randomised controlled trials conducted with patient aged 18 years or older were included. Two reviewers independently screened titles, abstracts and full texts, and assessed risk of bias using the Cochrane ROB-2 Tool. Study data was pooled using random effects meta-analyses.

Results

We included 26 studies in this review, and 25 in the meta-analyses (n = 2491). Preoperative oral carbohydrate loading reduced the overall risk (log RR: –0.35, 95 % CI: −0.62 to −0.08, I2 = 51.11 %) and severity (SMD: -0.46, 95 % CI: −0.68 to −0.24, I2 = 62.09 %) of PONV, and pain severity (MD: -0.69, 95 % CI: −1.13 to −0.25, I2 = 83.98 %) compared to prolonged fasting when pooled across both anaesthesia approaches. The risk of PONV was reduced in patients receiving inhalational anaesthesia, but not in those receiving TIVA, while the reduction in severity was more significant in TIVA.

Conclusion

Oral carbohydrate loading reduces the severity of PONV and pain, regardless of the anaesthesia approach, compared to prolonged fasting. These findings support the clinical advantages of oral carbohydrate loading for postoperative outcomes, regardless of anaesthesia approach.
背景:术前口服碳水化合物负荷被认为可以减少术后恶心和呕吐(PONV)。然而,目前尚不清楚在全静脉麻醉(TIVA)的情况下,碳水化合物负荷的益处是否能保持。本系统综述的目的是确定在接受TIVA或吸入性全身麻醉的成人择期手术患者中,与禁食相比,口服碳水化合物负荷是否能降低PONV。方法:截至2024年3月,检索7个数据库。纳入了18岁及以上患者进行的随机对照试验。两位审稿人独立筛选标题、摘要和全文,并使用Cochrane rob2工具评估偏倚风险。研究数据采用随机效应荟萃分析进行汇总。结果:本综述纳入26项研究,meta分析纳入25项研究(n = 2491)。术前口服碳水化合物负荷降低了PONV的总体风险(对数RR: -0.35, 95% CI: -0.62至-0.08,I2 = 51.11%)和严重程度(SMD: -0.46, 95% CI: -0.68至-0.24,I2 = 62.09%),以及疼痛严重程度(MD: -0.69, 95% CI: -1.13至-0.25,I2 = 83.98%)。在接受吸入麻醉的患者中,PONV的风险降低了,但在接受TIVA的患者中没有,而在TIVA患者中,严重程度的降低更为显著。结论:与长时间禁食相比,无论麻醉方式如何,口服碳水化合物负荷均可减轻PONV和疼痛的严重程度。这些发现支持口服碳水化合物负荷对术后预后的临床优势,无论麻醉方式如何。
{"title":"The effectiveness of preoperative oral carbohydrate loading on postoperative nausea and vomiting in adults receiving total intravenous anaesthesia compared to inhalational anaesthesia: A systematic review and meta-analysis","authors":"Oya Gumuskaya ,&nbsp;Hailey R. Donnelly ,&nbsp;Nick Glenn ,&nbsp;Julee McDonagh ,&nbsp;Anita Skaros ,&nbsp;Sophie Liang ,&nbsp;Brett G. Mitchell ,&nbsp;Luke Bendle ,&nbsp;Sarah Aitken ,&nbsp;Emile Belramoul ,&nbsp;Mitchell Sarkies","doi":"10.1016/j.jclinane.2025.112075","DOIUrl":"10.1016/j.jclinane.2025.112075","url":null,"abstract":"<div><h3>Background</h3><div>Preoperative oral carbohydrate loading is thought to reduce postoperative nausea and vomiting (PONV). However, it is unknown if the benefit of carbohydrate loading is maintained in the presence of total intravenous anaesthesia (TIVA). The aim of this systematic review was to determine whether oral carbohydrate loading reduced PONV compared to overnight fasting between adult elective surgery patients receiving TIVA or inhalational general anaesthesia.</div></div><div><h3>Methods</h3><div>A search of seven databases was conducted until March 2024. Randomised controlled trials conducted with patient aged 18 years or older were included. Two reviewers independently screened titles, abstracts and full texts, and assessed risk of bias using the Cochrane ROB-2 Tool. Study data was pooled using random effects meta-analyses.</div></div><div><h3>Results</h3><div>We included 26 studies in this review, and 25 in the meta-analyses (<em>n</em> = 2491). Preoperative oral carbohydrate loading reduced the overall risk (log RR: –0.35, 95 % CI: −0.62 to −0.08, I<sup>2</sup> = 51.11 %) and severity (SMD: -0.46, 95 % CI: −0.68 to −0.24, I<sup>2</sup> = 62.09 %) of PONV, and pain severity (MD: -0.69, 95 % CI: −1.13 to −0.25, I<sup>2</sup> = 83.98 %) compared to prolonged fasting when pooled across both anaesthesia approaches. The risk of PONV was reduced in patients receiving inhalational anaesthesia, but not in those receiving TIVA, while the reduction in severity was more significant in TIVA.</div></div><div><h3>Conclusion</h3><div>Oral carbohydrate loading reduces the severity of PONV and pain, regardless of the anaesthesia approach, compared to prolonged fasting. These findings support the clinical advantages of oral carbohydrate loading for postoperative outcomes, regardless of anaesthesia approach.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"108 ","pages":"Article 112075"},"PeriodicalIF":5.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145541026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intubating conditions based on the time from rocuronium administration versus the train-of-four count: A randomized, prospective, clinical trial 基于罗库溴铵给药时间与四列计数的插管条件:一项随机、前瞻性临床试验。
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-10 DOI: 10.1016/j.jclinane.2025.112066
J. Ross Renew , Maria Estevez , Mariel Maramba , Michael G. Heckman , Zhihui J. Fang , Sorin J. Brull , Richard H. Epstein

Background

The use of quantitative neuromuscular monitoring during induction of anesthesia to establish a baseline neuromuscular response and ensure paralysis of the vocal cords during laryngoscopy and tracheal intubation has yet to become standard practice. The current study compared intubating conditions based on quantitative measurements (train-of-four count) with intubating conditions based on the time since rocuronium administration.

Methods

Consenting adult patients undergoing general anesthesia requiring neuromuscular block were randomized into 2 groups. Following placement of a quantitative electromyographic neuromuscular monitor, general anesthesia was induced with propofol 1–1.5 mg/kg followed by rocuronium 0.6 mg/kg. In one group, intubation commenced 2 min after rocuronium administration (Time Group). In the other, intubation commenced when the first train-of-four (TOF) count was ≤1 (Count Group). Video laryngoscopy was used in both groups and the intubating conditions were noted. A Wilcoxon rank sum test or Fisher's exact test was used to compare intubating conditions between the 2 groups. Spearman's rank correlation test was used to describe the relationship between intubation conditions and the ratio of the amplitude of the first twitch of the TOF sequence, T1, to the control T1 amplitude (T1/Tc).

Results

There were 84 patients in the Count Group and 83 in the Time Group. More patients had ideal intubating conditions (relaxed jaw, abducted vocal cords, and no response to tracheal intubation) in the Count Group (61/84, 73 %) than the Time Group (47/83, 57 %, P = 0.036). The mean composite intubating score was better (lower) in the Count Group than in the Time Group (3.5 vs. 3.9, respectively, P = 0.016). The T1/Tc at intubation correlated with the composite intubating conditions score (Spearman's ρ = 0.34, P < 0.001).

Conclusion

Intubating conditions were better when the timing of intubation was guided by quantitative neuromuscular monitoring to ensure a TOF count ≤1 versus waiting a fixed time interval of 2 min following administration of rocuronium.
背景:在麻醉诱导过程中使用定量神经肌肉监测来建立基线神经肌肉反应并确保喉镜检查和气管插管时声带麻痹尚未成为标准做法。目前的研究比较了基于定量测量(四列计数)的插管条件和基于罗库溴铵给药后时间的插管条件。方法:自愿行全身麻醉需要神经肌肉阻滞的成年患者随机分为两组。放置定量肌电图神经肌肉监测仪后,丙泊酚1-1.5 mg/kg诱导全身麻醉,罗库溴铵0.6 mg/kg诱导全身麻醉。一组在罗库溴铵给药后2分钟开始插管(时间组)。另一组在TOF计数≤1(计数组)时开始插管。两组均行视频喉镜检查,观察插管情况。采用Wilcoxon秩和检验或Fisher精确检验比较两组间插管情况。采用Spearman秩相关检验描述插管条件与TOF序列第一次抽搐振幅T1与对照T1振幅之比(T1/Tc)之间的关系。结果:计数组84例,时间组83例。Count组患者插管条件理想(颌骨松弛、声带外展、气管插管无反应)的比例(61/ 84,73 %)高于Time组(47/ 83,57 %,P = 0.036)。Count组平均综合插管评分优于Time组(分别为3.5比3.9,P = 0.016)。插管时T1/Tc与复合插管条件评分相关(Spearman’s ρ = 0.34, P)结论:在定量神经肌肉监测指导下插管时机确保TOF计数≤1优于在给药后等待固定时间间隔2min。
{"title":"Intubating conditions based on the time from rocuronium administration versus the train-of-four count: A randomized, prospective, clinical trial","authors":"J. Ross Renew ,&nbsp;Maria Estevez ,&nbsp;Mariel Maramba ,&nbsp;Michael G. Heckman ,&nbsp;Zhihui J. Fang ,&nbsp;Sorin J. Brull ,&nbsp;Richard H. Epstein","doi":"10.1016/j.jclinane.2025.112066","DOIUrl":"10.1016/j.jclinane.2025.112066","url":null,"abstract":"<div><h3>Background</h3><div>The use of quantitative neuromuscular monitoring during induction of anesthesia to establish a baseline neuromuscular response and ensure paralysis of the vocal cords during laryngoscopy and tracheal intubation has yet to become standard practice. The current study compared intubating conditions based on quantitative measurements (train-of-four count) with intubating conditions based on the time since rocuronium administration.</div></div><div><h3>Methods</h3><div>Consenting adult patients undergoing general anesthesia requiring neuromuscular block were randomized into 2 groups. Following placement of a quantitative electromyographic neuromuscular monitor, general anesthesia was induced with propofol 1–1.5 mg/kg followed by rocuronium 0.6 mg/kg. In one group, intubation commenced 2 min after rocuronium administration (Time Group). In the other, intubation commenced when the first train-of-four (TOF) count was ≤1 (Count Group). Video laryngoscopy was used in both groups and the intubating conditions were noted. A Wilcoxon rank sum test or Fisher's exact test was used to compare intubating conditions between the 2 groups. Spearman's rank correlation test was used to describe the relationship between intubation conditions and the ratio of the amplitude of the first twitch of the TOF sequence, T<sub>1</sub>, to the control T<sub>1</sub> amplitude (T<sub>1</sub>/T<sub>c</sub>).</div></div><div><h3>Results</h3><div>There were 84 patients in the Count Group and 83 in the Time Group. More patients had ideal intubating conditions (relaxed jaw, abducted vocal cords, and no response to tracheal intubation) in the Count Group (61/84, 73 %) than the Time Group (47/83, 57 %, <em>P</em> = 0.036). The mean composite intubating score was better (lower) in the Count Group than in the Time Group (3.5 vs. 3.9, respectively, <em>P</em> = 0.016). The T<sub>1</sub>/T<sub>c</sub> at intubation correlated with the composite intubating conditions score (Spearman's <em>ρ</em> = 0.34, <em>P</em> &lt; 0.001).</div></div><div><h3>Conclusion</h3><div>Intubating conditions were better when the timing of intubation was guided by quantitative neuromuscular monitoring to ensure a TOF count ≤1 versus waiting a fixed time interval of 2 min following administration of rocuronium.</div></div>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"108 ","pages":"Article 112066"},"PeriodicalIF":5.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145495599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum to “Removal of EpCAM-positive tumor cells during intraoperative blood salvage– A pivotal multicenter clinical study (REMOVE)” [Journal of Clinical Anesthesia 106 (2025) 111972 (9 pages)] “术中血液回收过程中去除epcam阳性肿瘤细胞——一项关键的多中心临床研究(REMOVE)”[Journal of clinical Anesthesia 106(2025) 111972(9页)]的勘误。
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-01 Epub Date: 2025-08-28 DOI: 10.1016/j.jclinane.2025.111986
Patrick Meybohm MD , Suma Choorapoikayil PhD , Sebastian Zinn MD , Simone Lindau MD , Markus Heiss MD , Jerome Defosse MD , Eva Wittenmeier MD , Marion Ferner MD , Maximillian Kriegmair MD , Niklas Westhoff MD , Sebastian Hottenrott MD , Tobias Haas MD , Peter Kranke MD , Tom-Philipp Zucker MD , Andreas Schnitzbauer MD , Luis Kluth MD , Frank Wappler MD , Nina Walossek MD , Michael Schuster MD , Anna Lotz , Kai Zacharowski MD, PhD
{"title":"Erratum to “Removal of EpCAM-positive tumor cells during intraoperative blood salvage– A pivotal multicenter clinical study (REMOVE)” [Journal of Clinical Anesthesia 106 (2025) 111972 (9 pages)]","authors":"Patrick Meybohm MD ,&nbsp;Suma Choorapoikayil PhD ,&nbsp;Sebastian Zinn MD ,&nbsp;Simone Lindau MD ,&nbsp;Markus Heiss MD ,&nbsp;Jerome Defosse MD ,&nbsp;Eva Wittenmeier MD ,&nbsp;Marion Ferner MD ,&nbsp;Maximillian Kriegmair MD ,&nbsp;Niklas Westhoff MD ,&nbsp;Sebastian Hottenrott MD ,&nbsp;Tobias Haas MD ,&nbsp;Peter Kranke MD ,&nbsp;Tom-Philipp Zucker MD ,&nbsp;Andreas Schnitzbauer MD ,&nbsp;Luis Kluth MD ,&nbsp;Frank Wappler MD ,&nbsp;Nina Walossek MD ,&nbsp;Michael Schuster MD ,&nbsp;Anna Lotz ,&nbsp;Kai Zacharowski MD, PhD","doi":"10.1016/j.jclinane.2025.111986","DOIUrl":"10.1016/j.jclinane.2025.111986","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"108 ","pages":"Article 111986"},"PeriodicalIF":5.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144955306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unmasking the silent threat: Navigating the myocardial injury in oncological surgery 揭露无声的威胁:肿瘤手术中心肌损伤的导航。
IF 5.1 2区 医学 Q1 ANESTHESIOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-04 DOI: 10.1016/j.jclinane.2025.112063
Zhen-Zhen Xu , Dong-Liang Mu
{"title":"Unmasking the silent threat: Navigating the myocardial injury in oncological surgery","authors":"Zhen-Zhen Xu ,&nbsp;Dong-Liang Mu","doi":"10.1016/j.jclinane.2025.112063","DOIUrl":"10.1016/j.jclinane.2025.112063","url":null,"abstract":"","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"108 ","pages":"Article 112063"},"PeriodicalIF":5.1,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145450560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Anesthesia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1